瘤免疫微环境的小分子调节器
Jing Zhang1, Jia Yu1, Meijing Liu1
1Institute of Pharmacy and Pharmacology, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
Bioorganic chemistry
|March 5, 2024
概括
小分子药物在瘤免疫疗法中提供了独特的优势,补充了基于抗体的免疫检查点抑制剂. 本综述分析了小分子调制剂及其结构-活性关系,用于新型癌症治疗的开发.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 瘤免疫疗法增强了抗癌免疫反应,并减少了免疫抑制.
- 使用单克隆抗体 (mAbs) 阻断免疫检查点 (ICB) 是主要的治疗策略.
- 小分子药物在癌症免疫治疗中比生物药物具有明显的优势.
研究的目的:
- 审查瘤免疫疗法的机制.
- 分析小分子免疫调节剂的当前研究状况.
- 讨论小分子候选药物的结构-活性关系 (SAR).
主要方法:
- 关于瘤免疫治疗机制的文献综述.
- 对小分子免疫调节剂的研究分析.
- 对药物设计的结构-活性关系 (SAR) 的检查.
主要成果:
- 小分子药物在瘤免疫治疗中提供了独特的优势.
- 过度表达的免疫抑制信号 (例如PD-L1,IDO1,TGF-β) 创造了一个瘤免疫抑制的微环境.
- 多途径联合免疫疗法显示了经过验证的疗效.
结论:
- 小分子调节器对于推进瘤免疫治疗至关重要.
- 了解SAR是设计新型小分子免疫调节器的关键.
- 对小分子的进一步研究为癌症治疗提供了新的途径.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K